Oxford BioDynamics Plc (LON:OBD – Get Free Report) shares dropped 25.1% on Tuesday . The company traded as low as GBX 5.27 ($0.07) and last traded at GBX 5.50 ($0.07). Approximately 1,055,112 shares were traded during trading, an increase of 37% from the average daily volume of 771,017 shares. The stock had previously closed at GBX 7.34 ($0.09).
Analysts Set New Price Targets
Separately, Shore Capital reissued a “house stock” rating on shares of Oxford BioDynamics in a research report on Tuesday, June 4th.
Read Our Latest Stock Analysis on Oxford BioDynamics
Oxford BioDynamics Trading Down 25.1 %
About Oxford BioDynamics
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.
Read More
- Five stocks we like better than Oxford BioDynamics
- How to buy stock: A step-by-step guide for beginners
- Buffett Bails on BYD: What It Means for the Future of EV Stocks
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Domino’s vs. Papa John’s: Stock Showdown of Pizza Giants
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Williams-Sonoma Makes Stock More Accessible with a Stock Split
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.